About Us

Story and History

Since its founding in 1995, Faruqi & Faruqi has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, consumers and employees.

Values and Philosophy

Value is a core part of our firm's professional philosophy. We strive everyday to provide quality legal representation to our clients. This value driven approach is what you should expect from the law firm you select to handle your case. We demand that every member of our team deliver this value day in and day out.

Mission and Services

Faruqi & Faruqi, LLP is here to help our clients by providing them with a high degree of excellence in legal counsel.

Faruqi & Faruqi, LLP’s national practice focuses on complex civil litigation. The firm practices in the areas of Securities, Merger & Transactional, Shareholder Derivative, Antitrust, Consumer Class Action, Personal Injury and Employment litigation. The firm is headquartered in New York, and maintains offices in California, Delaware, Georgia and Pennsylvania.

Do you need legal assistance?

Do not hesitate to contact us with any enquiries.

(877) 247-4292 or (212) 983-9330

Stay up-to-date

Latest Postings from Our Offices

If you have a legal problem to discuss, call us for a free consultation.

Frequency Therapeutics, Inc. (FREQ)

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly ...

12 Jul 2021

Robert W. Killorin, James M. Wilson, Jr.

Take action

Athira Pharma, Inc. (ATHA)

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss ...

28 Jun 2021

Robert W. Killorin, James M. Wilson, Jr.

Take action

Emergent BioSolutions Inc. (EBS)

Faruqi & Faruqi, LLP is Investigating Emergent BioSolutions (EBS) on Behalf of its Shareholders Faruqi & Faruqi, LLP, a leading minority and Woman-owned ...

22 Jun 2021

Christopher M. Lash

Take action

DraftKings Inc. (DKNG)

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In DraftKings To Contact Him Directly To Discuss ...

16 Jun 2021

Robert W. Killorin, James M. Wilson, Jr.

Take action

Halman Aldubi Provident and Pension Funds Ltd. v. Teva Pharmaceutical Industries Limited et al, No. 20-cv-04660

In the Teva Pharmaceutical Industries securities case, Faruqi & Faruqi, LLP was appointed sole lead counsel. The lawsuit focuses on whether the Company ...

23 Sep 2020

Robert W. Killorin, James M. Wilson, Jr.

Take action

Varian Medical Systems, Inc. (VAR)

Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Northern District of California, ...

23 Sep 2020

James M. Wilson, Jr.

Take action

Jernigan Capital, Inc. (JCAP)

Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Southern District of New York, Case No. 1:20-cv-07160 ...

17 Sep 2020

James M. Wilson, Jr.

Take action

Maxim Integrated Products, Inc. (MXIM)

Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Southern District of New ...

15 Sep 2020

James M. Wilson, Jr.

Take action

F&F Defeats Motion To Dismiss In Emergen-C Case

On July 1, 2021 Faruqi & Faruqi, LLP scored a major victory in a lawsuit against Alacer Corp., the company that owns the popular immune support brand Emergen-C. ...

06 Jul 2021

Court Grants Collective Certification in the Mercado Action

Judge Analisa Torres of the United States District Court for the Southern District of New York ordered conditional certification of a collective action ...

30 Jun 2021

Innessa M. Huot

Faruqi & Faruqi Scores Big Lead Counsel Win in Folgers Coffee MDL

Chief Judge Beth Phillips, Western District of Missouri, today appointed Faruqi & Faruqi co-lead counsel for the putative class of consumers in the Folgers ...

07 Jun 2021

FARUQI & FARUQI, LLP, APPOINTED SOLE LEAD COUNSEL TO LEAD TEVA PHARMACEUTICALS SECURITIES LITIGATION

On March 26, 2021, United States District Court Judge Karen Spencer Marston of the United States District Court for the Eastern District of Pennsylvania ...

26 Mar 2021

Robert W. Killorin, James M. Wilson, Jr.

SEC Settles Charges against First American Financial Corporation over Cybersecurity Vulnerability

On June 15, 2021, the SEC settled its charges against First American Financial Corporation ("First American"), a real estate company, in the amount of ...

23 Jul 2021

Thomas T. Papain

Sexual Harassment Likely to Increase as Employees Return to the Office

In 2020, as the Coronavirus pandemic forced millions of employees to work remotely, the number of charges filed with Equal Employment Opportunity Commission ...

15 Jul 2021

Taylor Crabill

Biden White House Issues Sweeping Executive Order to Boost Competition and Increase Workers’ Pay

After months of being prematurely heralded as a "modern F.D.R.," President Joe Biden recently took a significant step toward beginning to justify the lofty ...

13 Jul 2021

Alex Hartzband

Supreme Court to Decide Whether PSLRA Discovery Stay Applies to State Securities Cases Under the Securities Act of 1933

Under the Private Securities Litigation Reform Act of 1995 ("PSLRA"), all discovery in a Federal securities lawsuit is put on hold while the court decides ...

08 Jul 2021

Daniel Weiss

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885

Delaware

3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612

Georgia

3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania

About Us

Story and History

Values and Philosophy

Mission and Services

Do you need legal assistance?

Stay up-to-date

Latest Postings from Our Offices

Frequency Therapeutics, Inc. (FREQ)

Athira Pharma, Inc. (ATHA)

Emergent BioSolutions Inc. (EBS)

DraftKings Inc. (DKNG)

Halman Aldubi Provident and Pension Funds Ltd. v. Teva Pharmaceutical Industries Limited et al, No. 20-cv-04660

Varian Medical Systems, Inc. (VAR)

Jernigan Capital, Inc. (JCAP)

Maxim Integrated Products, Inc. (MXIM)

F&F Defeats Motion To Dismiss In Emergen-C Case

Court Grants Collective Certification in the Mercado Action

Faruqi & Faruqi Scores Big Lead Counsel Win in Folgers Coffee MDL

FARUQI & FARUQI, LLP, APPOINTED SOLE LEAD COUNSEL TO LEAD TEVA PHARMACEUTICALS SECURITIES LITIGATION

SEC Settles Charges against First American Financial Corporation over Cybersecurity Vulnerability

Sexual Harassment Likely to Increase as Employees Return to the Office

Biden White House Issues Sweeping Executive Order to Boost Competition and Increase Workers’ Pay

Supreme Court to Decide Whether PSLRA Discovery Stay Applies to State Securities Cases Under the Securities Act of 1933

Finding us

Our Offices

New York

California

Delaware

Georgia

Pennsylvania